Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
Privia Health Group Inc (PRVA)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/12/2025: PRVA (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
21 Analysts rated it
Well-followed company, solid analyst reports, reliable data for confident investing.
1 Year Target Price $30.32
1 Year Target Price $30.32
| 14 | Strong Buy |
| 5 | Buy |
| 2 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -45.21% | Avg. Invested days 19 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 09/12/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 2.80B USD | Price to earnings Ratio 207.18 | 1Y Target Price 30.32 |
Price to earnings Ratio 207.18 | 1Y Target Price 30.32 | ||
Volume (30-day avg) 21 | Beta 0.82 | 52 Weeks Range 16.47 - 26.09 | Updated Date 09/14/2025 |
52 Weeks Range 16.47 - 26.09 | Updated Date 09/14/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.11 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 0.78% | Operating Margin (TTM) 0.64% |
Management Effectiveness
Return on Assets (TTM) 1.04% | Return on Equity (TTM) 2.71% |
Valuation
Trailing PE 207.18 | Forward PE 35.34 | Enterprise Value 2413531990 | Price to Sales(TTM) 1.47 |
Enterprise Value 2413531990 | Price to Sales(TTM) 1.47 | ||
Enterprise Value to Revenue 1.27 | Enterprise Value to EBITDA 87.04 | Shares Outstanding 122730000 | Shares Floating 98696951 |
Shares Outstanding 122730000 | Shares Floating 98696951 | ||
Percent Insiders 7.08 | Percent Institutions 97.06 |
Upturn AI SWOT
Privia Health Group Inc
Company Overview
History and Background
Privia Health Group Inc. was founded in 2007. Initially focused on physician practice management, Privia has evolved into a technology-driven, national physician enablement company that collaborates with medical groups, health plans, and health systems to optimize healthcare delivery and patient outcomes.
Core Business Areas
- Physician Enablement: Provides technology and services to support physician practices in areas such as revenue cycle management, value-based care programs, and population health management.
- Value-Based Care: Partners with payers to create value-based care arrangements that reward physicians for delivering high-quality, cost-effective care.
Leadership and Structure
Shawn Gupta is the Chief Executive Officer. The company operates with a structure of functional departments (e.g., operations, technology, finance) and regional market teams.
Top Products and Market Share
Key Offerings
- Privia Cloud: A technology platform that provides electronic health records (EHR), practice management, and analytics tools. While specific market share data is not publicly available, the adoption rate among affiliated physician practices serves as an indicator. Competitors include athenahealth, Epic Systems, and Cerner.
- Revenue Cycle Management (RCM) Services: Privia provides comprehensive RCM services to its affiliated practices. Specific revenue figures for this product are not broken out. Competitors include R1 RCM, Optum, and Conifer Health Solutions.
Market Dynamics
Industry Overview
The healthcare technology and physician enablement market is experiencing significant growth, driven by the shift to value-based care, increasing regulatory complexity, and the need for improved efficiency and patient outcomes.
Positioning
Privia is positioned as a comprehensive physician enablement platform, offering technology, services, and value-based care expertise. Its competitive advantages include its integrated platform, physician-led governance model, and focus on value-based care.
Total Addressable Market (TAM)
The estimated TAM for physician enablement services is substantial, expected to reach hundreds of billions of dollars annually. Privia is positioned to capture a significant portion of this market by expanding its network and service offerings.
Upturn SWOT Analysis
Strengths
- Comprehensive physician enablement platform
- Strong physician network
- Value-based care expertise
- Technology-driven approach
Weaknesses
- Dependence on physician adoption of its platform
- Concentration of revenue in certain markets
- Integration risks associated with acquisitions
Opportunities
- Expansion into new geographic markets
- Growth in value-based care arrangements
- Increased demand for telehealth and remote patient monitoring
- Partnerships with health systems and payers
Threats
- Increased competition from established players
- Regulatory changes impacting value-based care
- Cybersecurity risks
- Physician burnout and staffing shortages
Competitors and Market Share
Key Competitors
- ATHN
- CERN
- HQY
Competitive Landscape
Privia competes with larger, more established players like athenahealth and Cerner. Privia's advantages include its focus on value-based care and its integrated platform. Disadvantages include its smaller scale and geographic concentration.
Major Acquisitions
Maryland Primary Care Physicians (MPCP)
- Year: 2021
- Acquisition Price (USD millions): 225
- Strategic Rationale: Expanded Privia's presence in the Mid-Atlantic region and added a large network of primary care physicians.
Growth Trajectory and Initiatives
Historical Growth: Privia's historical growth has been driven by organic network expansion and strategic acquisitions.
Future Projections: Analyst estimates project continued revenue growth for Privia, driven by the increasing adoption of value-based care and the company's expansion into new markets.
Recent Initiatives: Recent initiatives include expanding its geographic footprint through acquisitions and partnerships, enhancing its technology platform, and developing new value-based care programs.
Summary
Privia Health Group Inc. is a growing physician enablement company with a strong focus on value-based care. Its comprehensive platform and physician-led model provide a competitive advantage, but it faces competition from larger, more established players. Growth is expected to continue through network expansion and strategic acquisitions. A key challenge will be managing integration risks and maintaining physician engagement.
Peer Comparison
Sources and Disclaimers
Data Sources:
- SEC Filings
- Company Investor Relations
- Industry Reports
- Analyst Estimates
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Market share data is based on available estimates and may not be precise. Financial data is subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Privia Health Group Inc
Exchange NASDAQ | Headquaters Arlington, VA, United States | ||
IPO Launch date 2021-04-28 | CEO & Director Mr. Parth Mehrotra | ||
Sector Healthcare | Industry Health Information Services | Full time employees 1140 | Website https://www.priviahealth.com |
Full time employees 1140 | Website https://www.priviahealth.com | ||
Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with physician practices, health plans, and health systems. It offers technology and population health tools to enhance providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; and single-TIN medical group that facilitates negotiating power, clinical integration, and alignment of financial incentives. The company also operates accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.